Highest-materiality recent filing
Calix increases stock repurchase authorization by $100M to $525M total
Board authorized an additional $100M for stock repurchases, bringing total authorization to $525M.
Calix Q1 record revenue $280M (+27% YoY); guides Q2 revenue $287-293M
Record Q1 revenue $280M, up 27% YoY; GAAP EPS $0.16, non-GAAP EPS $0.40.
Calix increases stock repurchase authorization by $125M to total $425M
Board authorized additional $125M stock repurchase, bringing total program authorization to $425M.
Calix reports record Q4 revenue $272.4M (+32% YoY); non-GAAP EPS $0.39 beats guidance
Record Q4 revenue $272.4M (+32% YoY); annual revenue reaches $1.0B (+20% YoY).
GAAP net income $15.7M ($0.22 EPS); non-GAAP net income $30.6M ($0.44 EPS) vs guidance $0.31-$0.37.
Calix Q2 revenue $241.9M (+22% YoY); non-GAAP EPS $0.33 beats guidance; record gross margin 56.8%
Revenue $241.9M (+10% q/q, +22% y/y); non-GAAP EPS $0.33 vs guidance $0.18–$0.24.
Calix announces death of Chief Commercial Operations Officer J. Matthew Collins on May 7, 2025
Chief Commercial Operations Officer J. Matthew Collins passed away May 7, 2025.
Calix Q1 record gross margin 56.2%, revenue $220.2M, non-GAAP EPS $0.19
Q1 revenue $220.2M (+6.9% QoQ, -2.7% YoY); GAAP net loss $4.8M ($0.07 loss per share); non-GAAP net income $13.1M ($0.19 per share).
Calix Q4 revenue $206.1M, GAAP loss $0.27, non-GAAP EPS $0.08; record gross margin 55.0%
Q4 revenue $206.1M, +2.6% sequentially but -22% YoY; GAAP net loss $0.27 per diluted share, non-GAAP EPS $0.08.
Calix reports Q3 rev $200.9M, down 24% YoY; GAAP EPS $(0.06), non-GAAP $0.13
Revenue $200.9M, up 1.4% sequentially but down 24% YoY; GAAP net loss $4.0M vs income $17.0M a year ago.
Calix Q2 revenue $198.1M (-24% YoY); record gross margin 55.1%; guides Q3 rev $198M-$204M
Revenue $198.1M, down 24% YoY and 12% sequentially; GAAP EPS ($0.12), non-GAAP EPS $0.09.
Calix Q1 2024 revenue $226.3M (-9% YoY); GAAP EPS $0.00, non-GAAP $0.21; Q2 guide weak
GAAP revenue $226.3M, down 9% YoY; GAAP net income $0.1M ($0.00 EPS); non-GAAP EPS $0.21.
Ellie Fields notified Calix, Inc. (the “Company”) that she would not be standing for re-election to the Board of Directors (“Board”) of the Company upon the expiration of her term at the Company’s upcoming annual meeting of stockholders scheduled to be held on May 8, 2025.
Also on March 21, 2025, the Board, acting upon the recommendation of the Nominating and Corporate Governance Committee of the Board, nominated Michael Berry for election to the Board as a Class III director with a term expiring at the 2028 annual meeting of stockholders, to fill the vacancy resulting from the expiration of Ms. Fields’ term at the annual meeting.
appointed Wade Oosterman to the Board as a Class II director
Max materiality 0.85 · Median 0.60 · Most common event earnings